Can Fite Biofarma Vs. Pluri Industry Stock Comparison

Sell

42

CANF
Can Fite Biofarma

Last Price:

1.96

Seasonality Move:

-6.94%

Sell

41

PLUR
Pluri

Last Price:

4.89

Seasonality Move:

22.76%

Sell

42

Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

41

Pluri (PLUR) is a Sell

Is Pluri a Buy, Sell or Hold?

The current Pluri [PLUR] share price is $4.90. The Score for PLUR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
PLUR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

The Can Fite Biofarma share price today is $1.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

PLUR Stock Price Chart

What is Pluri's stock price today?

The Pluri share price today is $4.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	35.7	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.96 - 2.5)	Sell
Bollinger Bands (100):	(1.98 - 3.06)	Sell

PLUR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.02	Buy
Relative Strength Index (14 RSI):	48.33	Sell
Chaikin Money Flow:	2590	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.45 - 5.27)	Buy
Bollinger Bands (100):	(4.88 - 5.74)	Sell

CANF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2	Sell
20-day SMA:	2.11	Sell
50-day SMA:	2.21	Sell
200-day SMA:	2.4	Sell
8-day EMA:	2.01	Sell
20-day EMA:	2.11	Sell
50-day EMA:	2.24	Sell
200-day EMA:	2.45	Sell

PLUR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.2	Sell
20-day SMA:	4.95	Sell
50-day SMA:	5.09	Sell
200-day SMA:	5.7	Sell
8-day EMA:	5.02	Sell
20-day EMA:	5	Sell
50-day EMA:	5.07	Sell
200-day EMA:	5.46	Sell

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

Pluri Earnings Growth & PLUR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Can Fite Biofarma Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pluri Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):